Tech Company Financing Transactions
Lineagen Funding Round
On 6/1/2012, Lineagen received $3.6 million in funding from private investors.
Transaction Overview
Company Name
Announced On
6/1/2012
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$3,600,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
2677 E Parleys Way
Salt Lake City, UT 84109
USA
Salt Lake City, UT 84109
USA
Phone
Website
Email Address
Overview
The company is developing a diagnostic platform that targets autism, multiple sclerosis, cancer and chronic obstructive pulmonary disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Paul
Vice President
Rena Vanzo
VP - Human Resources
Leanne Hill
VP - Operations
Mathew Harrison
VP - Sales
Jeffrey Knupp
Browse more venture capital transactions:
Prev: 6/1/2012: Seventh Sense Biosystems venture capital transaction
Next: 6/4/2012: SentreHEART venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC transactions on this site are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs